AARTIIND2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member AARTIIND2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentRevenue01Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentRevenue02Member AARTIIND2022-01-012022-03-31in-bse-fin:FourReportableSegmentRevenue01Member AARTIIND2022-01-012022-03-31in-bse-fin:FourReportableSegmentRevenue02Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentResults01Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentResults02Member AARTIIND2022-01-012022-03-31in-bse-fin:FourReportableSegmentResults01Member AARTIIND2022-01-012022-03-31in-bse-fin:FourReportableSegmentResults02Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentAssets01Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentAssets02Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2022-03-31in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2022-01-012022-03-31in-bse-fin:OneReportableSegmentLiabilities02Member AARTIIND2022-03-31in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AARTIIND 2021-04-01 2022-03-31 2022-05-20 INR Lakhs Yearly true Cash Flow Indirect Multi segment 2022-01-01 2022-03-31 Audited Standalone 17176700000.00 26300000.00 17203000000.00 8995400000.00 766200000.00 -682600000.00 1176600000.00 302000000.00 754400000.00 3635900000.00 14947900000.00 2255100000.00 0.00 2255100000.00 260000000.00 100000000.00 360000000.00 0.00 1895100000.00 0.00 0.00 0.00 0.00 1895100000.00 600000.00 1895700000.00 0.00 0.00 1812500000.00 5 5.23 5.23 0.00 0.00 5.23 5.23 0.00 0.01 The above results for the quarter and year ended March 31, 2022, have been reviewed by the Audit Committee and approved by the Board of Directors in their meetings held on May 27, 2022. For other Notes, kindly refer the Audited Financial Results made available on the Company's website www.aarti-industries.com and the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com . Multi segment 2021-04-01 2022-03-31 Audited Standalone 68652700000.00 32000000.00 68684700000.00 32668900000.00 2108800000.00 -2295400000.00 4335600000.00 1128800000.00 2814100000.00 12927900000.00 53688700000.00 14996000000.00 0.00 14996000000.00 1837500000.00 270000000.00 2107500000.00 0.00 12888500000.00 0.00 0.00 0.00 0.00 12888500000.00 250200000.00 13138700000.00 0.00 0.00 1812500000.00 5 56041700000.00 35.55 35.55 0.00 0.00 35.55 35.55 0.00 0.04 Other Expenses 3635900000.00 Other Expenses 12927900000.00 a) Speciality Chemicals 15859200000.00 b) Pharmaceuticals 3884700000.00 a) Speciality Chemicals 64650300000.00 b) Pharmaceuticals 12999300000.00 19743900000.00 77649600000.00 19743900000.00 77649600000.00 a) Speciality Chemicals 2354900000.00 b) Pharmaceuticals 667600000.00 a) Speciality Chemicals 15787100000.00 b) Pharmaceuticals 2203300000.00 3022500000.00 17990400000.00 302000000.00 1128800000.00 465400000.00 NOTES: 1) The Company at its Board meeting held on August 19, 2021 had considered and approved a Scheme of Arrangement (“Scheme”) whereby the Pharma Business and allied activities of Aarti Industries Limited (“Demerged Company”) would be demerged into Aarti Pharmalabs Limited (Formerly known as Aarti Organics Limited), a wholly owned subsidiary Company of Aarti Industries Limited (“the Resulting Company’), as a going concern basis with effect from the Appointed Date i.e. July 1, 2021. As per the Scheme The Demerged Company would demerge its Pharma business and allied activities along with a part of Speciality Chemical Business, which is a backward intergated facility providing feeding material to the Pharma Business. As per the restructuring proposed in the Scheme, the Company has restated the Segment Financials by reclassifying the part of Speciality Chemical Business (which is being demerged) under the Pharmaceuticals Segment in this segment report. The figures related to prior periods have also been rearranged in a similar manner. 2) Figures for the previous period have been regrouped or rearranged wherever necessary. 1865600000.00 2255100000.00 14996000000.00 a) Speciality Chemicals 70612900000.00 b) Pharmaceuticals 16755500000.00 87368400000.00 5430600000.00 92799000000.00 a) Speciality Chemicals 10329200000.00 b) Pharmaceuticals 2449800000.00 12779000000.00 2379800000.00 15158800000.00 1128800000.00 -4414700000.00 -6216800000.00 0.00 0.00 0.00 0.00 0.00 0.00 -1258600000.00 0.00 0.00 0.00 2814100000.00 0.00 0.00 0.00 0.00 0.00 0.00 24800000.00 0.00 0.00 0.00 0.00 -6400000.00 0.00 0.00 0.00 -7978400000.00 7017600000.00 0.00 0.00 0.00 2596200000.00 0.00 4421400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4200000.00 12994100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24800000.00 0.00 0.00 5700000.00 0.00 -12959400000.00 0.00 0.00 11866900000.00 0.00 0.00 0.00 0.00 0.00 531900000.00 3285800000.00 0.00 0.00 1268800000.00 1128800000.00 0.00 0.00 6715400000.00 -1822600000.00 0.00 -1822600000.00 4059900000.00 2237300000.00